Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 Diabetes
Clinical trial NCT01940965 · COMPLETED
Trial details
- NCT number
- NCT01940965
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2015-07-01
- Enrollment
- 294
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.